Drug Type mRNA |
Synonyms TERT 101, TERT-101, TERT101 |
Target |
Action modulators |
Mechanism TERT modulators(Telomerase reverse transcriptase modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver Cirrhosis | Preclinical | United States | 31 Dec 2020 |